Triangulating Clinically Meaningful Change in the Six-minute Walk Test in Individuals with Chronic Heart Failure: A Systematic Review
- PMID: 22993497
- PMCID: PMC3443464
Triangulating Clinically Meaningful Change in the Six-minute Walk Test in Individuals with Chronic Heart Failure: A Systematic Review
Abstract
Purpose: The purpose of the present review was to use existing, published data to provide an estimate of the amount of change in six-minute walk test distance (Δ6MWT) that represents a clinically meaningful change in individuals with chronic heart failure (CHF).
Methods: THE PRESENT REVIEW INCLUDED TWO SEPARATE LITERATURE SEARCHES OF THE CINAHL AND MEDLINE DATABASES FOR ARTICLES THAT: (1) reported the intraclass correlation coefficient (ICC) of the 6MWT in individuals with CHF, and (2) used the 6MWT along with either aerobic capacity or health-related quality of life (HRQL) as study endpoints in randomized controlled trials (RCTs) of exercise-based intervention for individuals with CHF. The ICCs were used to calculate the minimum detectable difference (MDD) at the 95% confidence interval for each included study. The Δ6MWT associated with aerobic capacity and HRQL within-group effect sizes for the intervention and control groups in each included RCT was analyzed using receiver operating characteristic (ROC) curves.
Results: Thirteen articles reported the ICC for the 6MWT. The mean (standard deviation) MDD calculated based on these data was 43.1(16.8) m. Eighteen RCTs measured the 6MWT and either aerobic capacity and/or HRQL. A Δ6MWT of 40-45 m was associated with at least moderate aerobic capacity and HRQL effect sizes in the intervention groups. The Δ6MWT thresholds that discriminated between intervention and control groups using ROC curves revealed the following sensitivity/specificity for the respective thresholds: 19 m, 94.4/83.3%, 32 m, 83.3/94.4%, and 48 m 44.4/100% (AUC = .935, p = .009, CI(95%) .855, 1.015).
Conclusions: A Δ6MWT of approximately 45 m appears to exceed measurement error and be associated with significant changes in either aerobic capacity and/or HRQL.
Keywords: clinically meaningful change; heart failure; minimum detectable difference; six-minute walk test.
Figures





Similar articles
-
Clinically meaningful change estimates for the six-minute walk test and daily activity in individuals with chronic heart failure.Cardiopulm Phys Ther J. 2013 Sep;24(3):21-9. Cardiopulm Phys Ther J. 2013. PMID: 23997688 Free PMC article.
-
Influence of step length on 6-minute walk test performance in patients with chronic heart failure.Physiotherapy. 2012 Dec;98(4):325-9. doi: 10.1016/j.physio.2011.08.005. Epub 2011 Oct 21. Physiotherapy. 2012. PMID: 23122439
-
Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer.Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD009955. doi: 10.1002/14651858.CD009955.pub3. Cochrane Database Syst Rev. 2019. PMID: 31204439 Free PMC article.
-
Six-Minute Walk Test for Assessing Physical Functional Capacity in Chronic Heart Failure.Curr Heart Fail Rep. 2017 Jun;14(3):158-166. doi: 10.1007/s11897-017-0330-3. Curr Heart Fail Rep. 2017. PMID: 28421409 Review.
-
Comparison of two 6-minute walk tests to assess walking capacity in polio survivors.J Rehabil Med. 2017 Nov 21;49(9):732-737. doi: 10.2340/16501977-2264. J Rehabil Med. 2017. PMID: 28929170
Cited by
-
Evaluation of the efficacy and safety of an integrated telerehabilitation platform for home-based cardiac REHABilitation in patients with heart failure (E-REHAB): protocol for a randomised controlled trial.BMJ Open. 2023 Aug 24;13(8):e073846. doi: 10.1136/bmjopen-2023-073846. BMJ Open. 2023. PMID: 37620273 Free PMC article.
-
Clinically meaningful change estimates for the six-minute walk test and daily activity in individuals with chronic heart failure.Cardiopulm Phys Ther J. 2013 Sep;24(3):21-9. Cardiopulm Phys Ther J. 2013. PMID: 23997688 Free PMC article.
-
Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial.Eur J Heart Fail. 2022 Jul;24(7):1239-1248. doi: 10.1002/ejhf.2527. Epub 2022 Jun 6. Eur J Heart Fail. 2022. PMID: 35596935 Free PMC article. Clinical Trial.
-
Inspiratory Muscle Weakness is Related to Poor Short-Term Outcomes for Heart Transplantation.Braz J Cardiovasc Surg. 2021 Jun 1;36(3):308-317. doi: 10.21470/1678-9741-2020-0344. Braz J Cardiovasc Surg. 2021. PMID: 33438847 Free PMC article.
-
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension.Pulm Circ. 2020 Nov 18;10(4):2045894020962960. doi: 10.1177/2045894020962960. eCollection 2020 Oct-Dec. Pulm Circ. 2020. PMID: 33282190 Free PMC article.
References
-
- Eriksson H. Heart failure: a growing public health problem. J Intern Med. 1995;237:135–141. - PubMed
-
- Perk J, Mathes P, Gohlke H, Monpere C, Hellemans I, McGee H, Sellier P, Saner H. Cardiovascular Prevention and Rehabilitation. London: Springer; 2007.
-
- Califf RM, Prystowsky EN, Thomas JD, Thompson PD, Topol EJ. Textbook of Cardiovascular Medicine. 3rd. Philadelphia, PA: Lippincott Williams & Wilkins;; 2007.
-
- Berra K, Hamm LF, Kavanagh T. Champaign, IL: Human Kinetics; 2006. AACVPR Cardiac Rehabilitation Resource Manual.
-
- Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Philedelphia, PA: Lippincott Williams & Wilkins; 2005. Principles of Exercise Testing and Interpretation.
LinkOut - more resources
Full Text Sources
Medical
Research Materials